A set of specific miRNAs is connected with murine and human gastric cancer

Genes Chromosomes and Cancer

Volumn 52, Issue 3, 2013, Pages 237-249

  Shah, Aftab Ali ^a,b,c   Leidinger, Petra ^c   Backes, Christina ^c   Keller, Andreas ^c,d   Karpinski, Pawel ^e   Sasiadek, Maria M ^e   Blin, Nikolaus ^a,e   Meese, Eckart ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MALAKAND   (Pakistan)

^c SAARLAND UNIVERSITY   (Germany)

^d SIEMENS AG   (Germany)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER PATIENT; CANCER TISSUE; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STOMACH CARCINOMA;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; STOMACH NEOPLASMS;

HOMO SAPIENS; MURINAE; MUS; MUS MUSCULUS;

EID: 84872374580     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22024     Document Type: Article

References (35)

1. Backes C, Keller A, Kuentzer J, Kneissl B, Comtesse N, Elnakady YA, Muller R, Meese E, Lenhof HP. 2007. GeneTrail-Advanced gene set enrichment analysis. Nucleic Acids Res 35: W186-W192.
2. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
3. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. 2001. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
4. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
5. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY. 2008. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
6. David S, Meltzer SJ. 2011. Stomach-Genetic and epigenetic alterations of preneoplastic and neoplastic lesions. Cancer Biomark 9: 493-507.
7. Garzon R, Calin GA, Croce CM. 2009. MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
8. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA. 2007. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468.
9. Griffiths-Jones S. 2004. The microRNA registry. Nucleic acids Res 32: D109-D111.
10. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. 2006. miRBase: MicroRNA sequences, targets and gene nomenclature. Nucleic acids Res 34: D140-D144.
11. Hochberg Y. 1988. A sharper bonferroni procedure for multiple tests of significance. Biometrica 75: 800-802.
12. Hoffmann W, Jagla W, Wiede A. 2001. Molecular medicine of TFF-peptides: From gut to brain. Histol Histopathol 16: 319-334.
13. Inui M, Martello G, Piccolo S. 2010. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
14. Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter R, Sansom OJ, Evans T, McKay CJ, Oien KA. 2012. MicroRNA molecular profiles associated with diagnosis, clinicopathological criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res 18: 534-545.
15. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, 2007. CA: Cancer J Clin 57: 43-66.
16. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA: Cancer J Clin 61: 69-90.
17. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. 2004. Human MicroRNA targets. PLoS Biol 2: e363.
18. Kelley JR, Duggan JM. 2003. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56: 1-9.
19. Keller A, Backes C, Al-Awadhi M, Gerasch A, Kuntzer J, Kohlbacher O, Kaufmann M, Lenhof HP. 2008. GeneTrailExpress: A web-based pipeline for the statistical evaluation of microarray experiments. BMC Bioinform 9: 552.
20. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP, Meese E. 2009a. miRNAs in lung cancer-Studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9: 353.
21. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E. 2009b. Multiple sclerosis: MicroRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PloS One 4: e7440.
22. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, Werner J, Hackert T, Ruprecht K, Huwer H, Huebers J, Jacobs G, Rosenstiel P, Dommisch H, Schaefer A, Muller-Quernheim J, Wullich B, Keck B, Graf N, Reichrath J, Vogel B, Nebel A, Jager SU, Staehler P, Amarantos I, Boisguerin V, Staehler C, Beier M, Scheffler M, Buchler MW, Wischhusen J, Haeusler SF, Dietl J, Hofmann S, Lenhof HP, Schreiber S, Katus HA, Rottbauer W, Meder B, Hoheisel JD, Franke A, Meese E. 2011. Toward the blood-borne miRNome of human diseases. Nat Methods 8: 841-843.
23. Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE. 2011. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genom 4: 79.
24. Kjellev S. 2009. The trefoil factor family-Small peptides with multiple functionalities. Cellular and molecular life sciences. Cell Mol Life Sci 66: 1350-1369.
25. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, Rio MC. 1996. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262.
26. Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, Klein V, Andres C, Staratschek-Jox A, Wolf J, Stoelben E, Stephan B, Stehle I, Hamacher J, Huwer H, Lenhof HP, Meese E. 2010. Identification of lung cancer with high sensitivity and specificity by blood testing. Respir Res 11: 18.
27. Madsen J, Nielsen O, Tornoe I, Thim L, Holmskov U. 2007. Tissue localization of human trefoil factors 1, 2, and 3. J Histochem Cytochem 55: 505-513.
28. Parkin DM, Pisani P, Ferlay J. 1999. Global cancer statistics. CA: Cancer J Clin 49: 33-64.
29. Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D, Xing J. 2010. Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med 33: E124.
30. Robinson MD, Oshlack A. 2010. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11: R25.
31. Shah AA, Leidinger P, Keller A, Wendschlag A, Backes C, Baus-Loncar M, Meese E, Blin N. 2011. The intestinal factor Tff3 and a miRNA network regulate murine caloric metabolism. RNA Biol 8: 77-81.
32. Shah AA, Leidinger P, Keller A, Wendschlag A, Meese E, Blin N. 2012. Altered miRNA expression patterns in Tff2 knock-out mice correlate with cellular pathways of neoplastic development and caloric metabolism. Int J Mol Med 29: 637-643.
33. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
34. Vorwerk S, Ganter K, Cheng Y, Hoheisel J, Stahler PF, Beier M. 2008. Microfluidic-based enzymatic on-chip labeling of miRNAs. New Biotechnol 25: 142-149.
35. Zhang H, Li Y, Lai M. 2010. The microRNA network and tumor metastasis. Oncogene 29: 937-948.